{"nct_id":"NCT00558103","title":"Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer","status":"COMPLETED","status_verified_date":"2013-01","start_date":"2007-12","start_date_type":null,"primary_completion_date":"2011-05","primary_completion_date_type":"ACTUAL","completion_date":"2011-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}